查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1657980

體外受精服務市場評估:各次序類型，各服務供應商，各終端用戶，各地區，機會及預測，2018～2032年

In-Vitro Fertilization Services Market Assessment, By Procedure Type, By Service Provider, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 247 Pages | 商品交期: 3-5個工作天內

價格

全球 IVF 服務市場預計將從 2024 年的 236.7 億美元成長到 2032 年的 518.6 億美元，在 2025-2032 年預測期內的複合年增長率為 10.30%。體外受精 (IVF) 方法的最新發展和對有效解決方案日益增長的需求極大地擴展了全球 IVF 服務市場。由於環境因素的變化和久坐的生活方式導致很大一部分人口的生殖功能下降是推動市場擴張的主要因素之一。該國許多人擁有可支配收入，這使他們能夠照顧自己的健康並為自己的福祉花錢，尤其是在涉及如此重要且改變生活的程序時。此外，政府對醫療保健基礎設施的投資、技術改進以及對尖端技術的日益增長的需求正在加強市場的成長軌跡。新興地區（尤其是亞太地區）醫療保健的快速改善正在提供收入機會。例如，科羅拉多州 Concepts Reproductive Associates（Conceptions）於 2023 年 8 月被 Reproductive Medicine Associates（RMA）收購。作為收購的一部分，Conceptions 位於科羅拉多州的四家生育診所將加入 RMA。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 體外受精服務的全球市場的展望，2018年～2032年

  • 市場規模的分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 各次序類型
      • 新鮮捐贈者的體外受精
      • 新鮮的非捐贈者體外受精
      • 凍結捐贈者體外受精
      • 凍結非捐贈者體外受精
      • 自然地週期體外受精
      • 胚銀行(凍結保存)
    • 各服務供應商
      • 不孕治療診所
      • 醫院
      • 外科中心
      • 冷凍銀行
    • 各終端用戶
      • 情侶(男性與女性的不孕症)
      • 單身女性
      • LGBTQ+地方自治團體
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東及非洲
    • 市場佔有率分析(前五名公司以及其他- 各金額，2024年)，各企業
  • 市場地圖分析，2024年
    • 各次序類型
    • 各服務供應商
    • 各終端用戶
    • 各地區

第5章 北美的體外受精服務市場展望，2018年～2032年

  • 市場規模的分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 各次序類型
      • 新鮮捐贈者的體外受精
      • 新鮮的非捐贈者體外受精
      • 凍結捐贈者體外受精
      • 凍結非捐贈者體外受精
      • 自然地週期體外受精
      • 胚銀行(凍結保存)
    • 各服務供應商
      • 不孕治療診所
      • 醫院
      • 外科中心
      • 冷凍銀行
    • 各終端用戶
      • 情侶(男性與女性的不孕症)
      • 單身女性
      • LGBTQ+地方自治團體
    • 各國佔有率
      • 美國
      • 加拿大
      • 墨西哥
  • 各國市場評估
    • 美國的體外受精服務市場預測，2018年～2032年
      • 市場規模的分析與預測
      • 市場佔有率分析與預測

所有市場區隔均提供所有對象地區和國家。

第6章 歐洲的體外受精服務市場展望，2018年～2032年

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 土耳其
  • 波蘭

第7章 亞太地區的體外受精服務市場展望，2018年～2032年

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的體外受精服務市場預測，2018年～2032年

  • 巴西
  • 阿根廷

第9章 中東及非洲的體外受精服務市場預測，2018年～2032年

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 需求供給分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 大環境分析

第14章 價格分析

第15章 市場動態

  • 推動市場要素
  • 市場課題

第16章 市場趨勢與發展

第17章 法規結構和革新

第18章 案例研究

第19章 競爭情形

  • 前五名市場領導公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大市場主要企業的形勢
    • Weill Cornell Medicine
      • 公司概要
      • 主要經營團隊
      • 產品和服務
      • 財務狀況(如報告)
      • 主要市場焦點和地理存在感
      • 最近的趨勢/合作/夥伴關係/合併和收購
    • IVI-RMA Global(Spain)
    • Dunya IVF Clinic(North Cyprus)
    • Kyrenia IVF Center(North Cyprus)
    • Memorial Sisli Hospital IVF Center(Turkey)
    • Gennet City Fertility(United Kingdom)
    • Dr. Ricardo Garcia Clinic(Mexico)
    • Takara IVF Bangkok(Thailand)
    • Azul Fertility Experts(Spain)
    • Beta Plus Fertility Clinic(Greece)

上述公司不依市場佔有率排序，並且可能會根據研究工作期間獲得的資訊進行更改。

第20章 策略性建議

第21章 關於調查公司·免責聲明

Product Code: MX12762

Global in-vitro fertilization services market is projected to witness a CAGR of 10.30% during the forecast period 2025-2032, growing from USD 23.67 billion in 2024 to USD 51.86 billion in 2032. Recent developments in in-vitro fertilization (IVF) methods and the rising need for effective solutions have seen a huge expansion in the global market for in-vitro fertilization services. Declining reproductive health in most of the population due to changing environmental factors and sedentary lifestyles is one of the main reasons driving market expansion. Most of the population has a disposable income to take care of their health and spend on their well-being especially when it comes to such critical and life-altering operations. In addition, government investments in healthcare infrastructure, technological improvements, and the increasing need for state-of-the-art technologies are reinforcing the market's growth trajectory. Fast improvements in healthcare in emerging regions, especially in Asia-Pacific, offer profitable opportunities. For example, Conceptions Reproductive Associates of Colorado (Conceptions) was acquired by Reproductive Medicine Associates (RMA) in August 2023. Four of Conceptions' fertility clinics in Colorado will join RMA as part of the transaction.

Changing Lifestyles Among People Boost Market Growth

Lifestyle changes have greatly contributed to the increased demand for in vitro fertilization (IVF) services globally. The growing tendency of postponed motherhood, fueled by late marriages, financial preparation, and career goals, is one of the main causes. Fertility decreases with maternal age, which is why many couples turn to assisted reproductive technologies (ART) such as IVF. Furthermore, hormonal imbalances and issues related to the reproductive system in both men and women have been connected to contemporary lives marked by high levels of stress, erratic sleep patterns, and unhealthy eating habits. Fertility treatments are required because of disorders including polycystic ovarian syndrome (PCOS) and decreased sperm quality, which are further aggravated by sedentary behavior and rising obesity rates. Furthermore, environmental risks that have been linked to decreased reproductive health include exposure to radiation, pollution, and endocrine-disrupting chemicals (EDCs). Substance abuse, such as excessive drinking, smoking, and drug use, also impairs fertility, leading some people to turn to IVF as a remedy. The IVF market is also growing because of changing social conventions, such as the growing acceptance of single parents and same-sex couples choosing assisted reproduction.

The need for IVF services is anticipated to increase as these lifestyle factors continue to affect conception rates, propelling improvements in reproductive medicine and increasing access to fertility care globally. For instance, as of 2023, approximately 12 million children have been born through assisted reproductive technologies (ART), with over 500,000 IVF deliveries occurring annually.

Technological Development and Integration of AI Fuel Market Growth

Due to technological improvements that have improved treatment efficiency and success rates, the global market is expanding significantly. IVF has become a more dependable choice for infertile couples over the past years because of advancements such as time-lapse imaging, preimplantation genetic testing (PGT), and embryo vitrification, which have increased implantation rates and decreased miscarriage risks. In addition to boosting patient confidence, these technical advancements have broadened the pool of eligible patients to include people with age-related infertility or genetic problems.

IVF is further revolutionized by automation and artificial intelligence (AI), which minimize human error and optimize embryo selection. Due to AI-driven models' capacity to precisely assess embryo viability, pregnancy success rates are surging. Furthermore, patients can maintain their fertility for later use by using cryopreservation techniques, such as storing oocytes and embryos, which raises the need for IVF services. IVF treatments are now more widely available and reasonably priced because of these developments, growing awareness, and increased investments in fertility clinics. Therefore, technological advancements in IVF remain a major driver of the market's steady expansion. For instance, a company based in the field of AI-based solutions for IVF clinics, called AIVF Ltd., joined forces with Genea Biomedx Pty Ltd, a medical device provider for IVF laboratories, in May 2023, to create a comprehensive and cost-effective integrated systems solution for personalized IVF. The collaboration brought together Genea Biomedx's Geri time-lapse incubator and AIVF Ltd.'s EMA AI platform, creating a powerful suite that offers widespread access to personalized and optimized IVF treatments.

Frozen Non-Donor IVF Segment Spearheads the Market Growth

Considering the market size and popularity, frozen non-donor IVF dominates the other IVF procedures because of its higher success rates, cost-effectiveness, and flexibility compared to fresh cycles. In this process, a woman's embryos from a prior cycle are frozen and used for implantation later. Due to improvements in cryopreservation methods, especially vitrification, frozen embryo transfers now have success rates that are on par with or even greater than those of fresh embryo transfers. One of the main benefits of frozen non-donor IVF is that it lessens the financial and physical burden on patients. Frozen cycles do not require recurrent ovarian stimulation and egg retrieval, which makes the procedure less invasive and less expensive than fresh IVF cycles.

Furthermore, frozen embryos are frequently subjected to preimplantation genetic testing (PGT), which guarantees the selection of genetically sound embryos and raises the likelihood of a successful pregnancy while lowering the risk of miscarriage. The demand for this operation has been greatly increased by the growing trend of fertility preservation, in which women preserve their embryos for later use. Furthermore, frozen non-donor IVF is a key driver of development in the global IVF market owing to the growing awareness, accessibility, and success of frozen cycles, further expanding its usage globally. Ovation Fertility and US Fertility merged in May 2023 to build a fertility platform that provides IVF and advanced fertility care, such as Frozen Non-Donor IVF, in the United States.

North America Dominates In-Vitro Fertilization Services Market Share

Due to strong regulatory support, high infertility rates, and advanced healthcare infrastructure, North America leads the global in-vitro fertilization (IVF) market. Due to delayed parenthood, changing lifestyle patterns, and greater awareness of fertility treatments, the region, especially the United States and Canada, has seen an increase in demand for assisted reproductive technologies (ART).

Furthermore, infertility issues affect a sizable section of the population, with variables such as stress, obesity, and environmental contaminants contributing to dwindling fertility rates. Technological developments further improve IVF success rates in North America in Preimplantation Genetic Testing (PGT), embryo cryopreservation, and artificial intelligence (AI)-based embryo selection. IVF is now more accessible to a wider audience due to the widespread availability of fertility clinics and specialist IVF centers and rising insurance coverage for infertility treatments. Furthermore, the market's reach has been broadened by the increasing acceptance of IVF among single parents and the LGBTQ+ community.

Innovative fertility solutions have been developed more quickly due to government initiatives and strong R&D funding from the corporate and governmental sectors. For instance, the U.S. FDA regulates drugs and devices used in IVF, followed by the CDC's implementation of the Fertility Clinic Success Rate and Certification Act. Moreover, semen analysis and sperm function tests are high-complexity tests regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) in the U.S. Strict compliance with standards and on-site inspections are essential. Significant medical tourism is also drawn to the area, especially by individuals seeking advanced care. Together, these factors position North America as the largest IVF market, with further expansion anticipated in the future.

Future Market Scenario (2025 - 2032F)

Many factors claim the growth of the in-vitro fertilization services market. Technological advancements provide faster, more accurate and promising results. Opportunity also lies in the increasing number of populations aware of such alternatives and choosing to beat the taboo associated with it. Promising government encompass providing healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone. For instance, the capabilities of FUJIFILM Irvine Scientific, Inc.'s Presagen's Life Whisperer platform were extended in June 2023 to support clinical decision-making in IVF.

Key Players Landscape and Outlook

Key service providers in the in-vitro fertilization services industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, Merck KGaA launched Fertility Counts in May 2023 to address the social, economic, and societal issues brought on by low birth rates in the Asia-Pacific area.

Furthermore, Boston IVF and Cryoport, Inc. signed a three-year supply chain solutions agreement in April 2023 to facilitate shipping reproductive materials across the United States.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Procedure Type
      • 4.2.1.1. Fresh Donor IVF
      • 4.2.1.2. Fresh Non-Donor IVF
      • 4.2.1.3. Frozen Donor IVF
      • 4.2.1.4. Frozen Non-Donor IVF
      • 4.2.1.5. Natural Cycle IVF
      • 4.2.1.6. Embryo Banking (Cryopreservation)
    • 4.2.2. By Service Provider
      • 4.2.2.1. Fertility Clinics
      • 4.2.2.2. Hospitals
      • 4.2.2.3. Surgical Centers
      • 4.2.2.4. Cryobanks
    • 4.2.3. By End-user
      • 4.2.3.1. Couples (Male & Female Infertility)
      • 4.2.3.2. Single Women
      • 4.2.3.3. LGBTQ+ Community
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Procedure Type
    • 4.3.2. By Service Provider
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America In-Vitro Fertilization Services Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Procedure Type
      • 5.2.1.1. Fresh Donor IVF
      • 5.2.1.2. Fresh Non-Donor IVF
      • 5.2.1.3. Frozen Donor IVF
      • 5.2.1.4. Frozen Non-Donor IVF
      • 5.2.1.5. Natural Cycle IVF
      • 5.2.1.6. Embryo Banking (Cryopreservation)
    • 5.2.2. By Service Provider
      • 5.2.2.1. Fertility Clinics
      • 5.2.2.2. Hospitals
      • 5.2.2.3. Surgical Centers
      • 5.2.2.4. Cryobanks
    • 5.2.3. By End-user
      • 5.2.3.1. Couples (Male & Female Infertility)
      • 5.2.3.2. Single Women
      • 5.2.3.3. LGBTQ+ Community
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States In-Vitro Fertilization Services Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Procedure Type
          • 5.3.1.2.1.1. Fresh Donor IVF
          • 5.3.1.2.1.2. Fresh Non-Donor IVF
          • 5.3.1.2.1.3. Frozen Donor IVF
          • 5.3.1.2.1.4. Frozen Non-Donor IVF
          • 5.3.1.2.1.5. Natural Cycle IVF
          • 5.3.1.2.1.6. Embryo Banking (Cryopreservation)
        • 5.3.1.2.2. By Service Provider
          • 5.3.1.2.2.1. Fertility Clinics
          • 5.3.1.2.2.2. Hospitals
          • 5.3.1.2.2.3. Surgical Centers
          • 5.3.1.2.2.4. Cryobanks
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Couples (Male & Female Infertility)
          • 5.3.1.2.3.2. Single Women
          • 5.3.1.2.3.3. LGBTQ+ Community

All segments will be provided for all regions and countries covered

6. Europe In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. Weill Cornell Medicine
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 19.3.2. IVI-RMA Global (Spain)
    • 19.3.3. Dunya IVF Clinic (North Cyprus)
    • 19.3.4. Kyrenia IVF Center (North Cyprus)
    • 19.3.5. Memorial Sisli Hospital IVF Center (Turkey)
    • 19.3.6. Gennet City Fertility (United Kingdom)
    • 19.3.7. Dr. Ricardo Garcia Clinic (Mexico)
    • 19.3.8. Takara IVF Bangkok (Thailand)
    • 19.3.9. Azul Fertility Experts (Spain)
    • 19.3.10. Beta Plus Fertility Clinic (Greece)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 3. Global In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 4. Global In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global In-Vitro Fertilization Services Market Share (%), By Region, 2018-2032F
  • Figure 6. North America In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 8. North America In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 9. North America In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 11. United States In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 13. United States In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 14. United States In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 17. Canada In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 18. Canada In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 21. Mexico In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 22. Mexico In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 25. Europe In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 26. Europe In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 30. Germany In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 31. Germany In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 32. France In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 34. France In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 35. France In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 38. Italy In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 39. Italy In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 42. United Kingdom In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 43. United Kingdom In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 46. Russia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 47. Russia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 50. Netherlands In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 51. Netherlands In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 54. Spain In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 55. Spain In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 58. Turkey In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 59. Turkey In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 62. Poland In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 63. Poland In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 66. South America In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 67. South America In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 71. Brazil In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 72. Brazil In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 75. Argentina In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 76. Argentina In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 79. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 80. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 82. India In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 84. India In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 85. India In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 86. China In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 88. China In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 89. China In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 92. Japan In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 93. Japan In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 96. Australia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 97. Australia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 100. Vietnam In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 101. Vietnam In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 104. South Korea In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 105. South Korea In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 108. Indonesia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 109. Indonesia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 112. Philippines In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 113. Philippines In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 116. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 117. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 121. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 122. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 125. UAE In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 126. UAE In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 129. South Africa In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 130. South Africa In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Procedure Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Service Provider Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024